Actualité


Nature, J Clin Invest, Cell Rep, Nat Chem Biol: nos 5 dernières publications

Catégorie : Publications du CRCM à la Une

Immune evasion before tumour invasion in early lung squamous carcinogenesis.

Mascaux C, Angelova M, Vasaturo A, Beane J, Hijazi K, Anthoine G, Buttard B, othe F , Willard-Gallo K, Haller A, Ninane V, Burny A, Sculier JP, Spira A, Galon J

Nature. 2019 Jun 26. doi: 10.1038/s41586-019-1330-0. 

www.ncbi.nlm.nih.gov/pubmed/31243362

 

Sensitive and easy screening for circulating tumor cells by flow cytometry.

Lopresti A, Malergue F, Bertucci F, Liberatoscioli ML, Garnier S, DaCosta Q, Finetti P, Gilabert M, Raoul JL, Birnbaum D, Acquaviva C, Mamessier E.

JCI Insight. 2019 Jun 13;5. pii: 128180. doi: 10.1172/jci.insight.128180.

www.ncbi.nlm.nih.gov/pubmed/31194699 

 

 

Genomic characterization of metastatic breast cancers.

Bertucci F, Ng CKY, Patsouris A, Droin N, Piscuoglio S, Carbuccia N, Soria JC, Tran Dien A, Adnani Y, Kamal M, Garnier S, Meurice G, Jimenez M, Tabernero J, Chia S, Martinalbo J, Perez-Moreno P, Dogan S, Verret B, Chaffanet M, Bacelot T, Campone M, Lefeuvre C, Bonnefoi H, Dalenc F, Jacquet A, De Filippo MR, Babbar N, Birnbaum D, Filleron D, Le Tourneau C & André F.

Nature 2019, doi.org/10.1038/s41586-019-1056-z  

 

 

Ligand-based design of a potent inhibitor of NUPR1 exerting anticancer activity via necroptosis

Santofimia-Catano P, Xia Y, Lan W, Zhou Z, Huang C, Peng L, Soubeyran P, Velazquez-Campoy A, Abian O, Rizzuti B, Neira JL, Iovanna JL.

Journal of Clinical Investigations 2019, doi.org/10.1172/JCI127223

www.ncbi.nlm.nih.gov/pubmed/30920390  

 

Nidogen-1 contributes to the interaction network involved in pro B cell retention in the perisinusoidal hematopoietic stem cell niche.

Balzano M, De Grandis M, Vu-Manh T-P, Chasson L, Bardin F, Farina A, Sergé A, Bidaut G, Charbord P, Herault, Bailly A-L, Michaud Cartier A, Boned A, Dalod M, Duprez E, Genever P, Coles M, Bajenoff M, Xerri L, Aurrand-Lions M, Schiff C & Mancini S

Cell Reports 2019 doi 10.1016/j.celrep.2019.02.065

www.ncbi.nlm.nih.gov/pubmed/

 

 

PH-domain-binding inhibitors of nucleotide exchange factor BRAG2 disrupt Arf GTPase signaling.

Nawrotek A, Benabdi S, Niyomchon S, Kryszke MH, Ginestier C, Cañeque T, Tepshi L, Mariani A, St Onge RP, Giaever G, Nislow C, Charafe-Jauffret E, Rodriguez R, Zeghouf M, Cherfils J.

Nat Chem Biol. 2019 Feb 11. doi: 10.1038/s41589-019-0228-3. 

www.nature.com/articles/s41589-019-0228-3